论文部分内容阅读
目的：探讨术后放化疗对可手术的服乳腺癌的远期效果。方法，可手术的乳腺癌27例。分为两组，术后放化组（A组）13例；术后化疗组（B组）14例。A组于术后两周内放疗．休2周行化疗；B组术后休2周行化疗。两组化疗方案和完成周期相同。结果：（1）Ⅲ期患者中，A组5年生存车（OS）61．5％，无病生存率（DFS）53．8％，均高于B组14．3％和7．14％（P＜0．05）。结论：可手术的Ⅲ期乳腺癌，术后放疗＋化疗可提高患者5年生存率。
Objective: To investigate the long-term effects of postoperative radiotherapy and chemotherapy on operable breast cancer. Methods, surgically treated breast cancer in 27 cases. Divided into two groups, postoperative radiochemotherapy group (A group) 13 cases; postoperative chemotherapy group (B group) 14 cases. In group A, radiotherapy was performed within two weeks after operation. After 2 weeks of chemotherapy, group B received chemotherapy 2 weeks after surgery. The two groups have the same chemotherapy schedule and completion cycle. Results: (1) In stage III patients, the 5-year survival car (OS) of group A was 61.5%, and the disease-free survival rate (DFS) was 53.8%, which was higher than that of group B 14.3% and 7.14%. (P<0.05). Conclusion: Operative stage III breast cancer, postoperative radiotherapy plus chemotherapy can improve 5-year survival.